A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain

Clinical trial NCT01439100 · COMPLETED

Trial details

NCT number: NCT01439100
Sponsor: Mundipharma Research GmbH & Co KG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson's Disease With Severe Pain

Start date: 2011-10-01
Primary completion: 2013-08-01
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.